Bakterie, wirusy i odczyn zapalny w podwzgórzu: Nowe czynniki w patogenezie otyłości

GLOSA LUB KOMENTARZ PRAWNICZY

Bakterie, wirusy i odczyn zapalny w podwzgórzu: Nowe czynniki w patogenezie otyłości

Magdalena Wierucka-Rybak 1 , Ewa Bojanowska 1

1. Department of Behavioral Pathophysiology, Institute of General and Experimental Pathology, Medical University of Lodz

Opublikowany: 2014-03-12
DOI: 10.5604/17322693.1093928
GICID: 01.3001.0003.1202
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2014; 68 : 271-279

 

Abstrakt

Przypisy

  • 1. Almgren M., Atkinson R., He J., Hilding A., Hagman E., Wolk A.,Thorell A., Marcus C., Näslund E., Östenson C.G., Schalling M., LavebrattC.: Adenovirus-36 is associated with obesity in children and adultsin Sweden as determined by rapid ELISA. PLoS One, 2012; 7: e41652
    Google Scholar
  • 2. Atkinson R.L.: Viruses as an etiology of obesity. Mayo Clin. Proc.,2007; 82: 1192-1198
    Google Scholar
  • 3. Atkinson R.L., Dhurandhar N.V., Allison D.B., Bowen R.L., IsraelB.A., Albu J.B., Augustus A.S.: Human adenovirus-36 is associatedwith increased body weight and paradoxical reduction of serumlipids. Int. J. Obes., 2005; 29: 281-286
    Google Scholar
  • 4. Bäckhed F., Crawford P.A.: Coordinated regulation of the metabolomeand lipidome at the host-microbial interface. Biochim. Biophys.Acta, 2010; 1801: 240-245
    Google Scholar
  • 5. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., SemenkovichC.F., Gordon J.I.: The gut microbiota as an environmentalfactor that regulates fat storage. Proc. Natl. Acad. Sci. USA, 2004;101: 15718-15723
    Google Scholar
  • 6. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I.:Host-bacterial mutualism in the human intestine. Science, 2005;307: 1915-1920
    Google Scholar
  • 7. Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.I.: Mechanismsunderlying the resistance to diet-induced obesity in germ-freemice. Proc. Natl. Acad. Sci. USA, 2007; 104: 979-984
    Google Scholar
  • 8. Bajzer M., Seeley R.J.: Obesity and gut flora. Nature, 2006; 444:1009-1010
    Google Scholar
  • 9. Björntorp P.: Do stress reactions cause abdominal obesity andcomorbidities? Obes. Rev., 2001; 2: 73-86
    Google Scholar
  • 10. Boogerd A., Alverdy J., Kumar S., Olson D.L., Schwenk W.F.: PartIII. Obesity. Dis. Mon., 2002; 48: 725-742
    Google Scholar
  • 11. Brinkworth G.D., Noakes M., Clifton P.M., Bird A.R.: Comparativeeffects of very low-carbohydrate, high-fat and high-carbohydrate,low-fat weight-loss diets on bowel habit and faecal short-chain fattyacids and bacterial populations. Br. J. Nutr., 2009; 101: 1493-1502
    Google Scholar
  • 12. Broderick M.P., Hansen C.J., Irvine M., Metzgar D., Campbell K.,Baker C., Russell K.L.: Adenovirus 36 seropositivity is strongly associatedwith race and gender, but not obesity, among US militarypersonnel. Int. J. Obes., 2010; 34: 302-308
    Google Scholar
  • 13. Cai D.: NFκB-mediated metabolic inflammation in peripheraltissues versus central nervous system. Cell Cycle, 2009; 8: 2542-2548
    Google Scholar
  • 14. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D.,Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmée E.,Cousin B., Sulpice T., Chamontin B. et al.: Metabolic endotoxemiainitiates obesity and insulin resistance. Diabetes, 2007; 56: 1761-1772
    Google Scholar
  • 15. Cani P.D., Delzenne N.M.: Gut microflora as a target for energyand metabolic homeostasis. Curr. Opin. Clin. Nutr. Metab. Care,2007; 10: 729-734
    Google Scholar
  • 16. Cani P.D., Delzenne N.M.: The gut microbiome as therapeutictarget. Pharmacol. Ther., 2011; 130: 202-212
    Google Scholar
  • 17. Cani P.D., Lecourt E., Dewulf E.M., Sohet F.M., Pachikian B.D.,Naslain D., De Backer F., Neyrinck A.M., Delzenne N.M.: Gut microbiotafermentation of prebiotics increases satietogenic and incretin gutpeptide production with consequences for appetite sensation andglucose response after a meal. Am. J. Clin. Nutr., 2009; 90: 1236-1243
    Google Scholar
  • 18. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., TuohyK.M., Gibson G.R., Delzenne N.M.: Selective increases of bifidobacteriain gut microflora improve high-fat-diet-induced diabetes in micethrough a mechanism associated with endotoxaemia. Diabetologia,2007; 50: 2374-2383
    Google Scholar
  • 19. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A.,Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., MuccioliG.G., Delzenne N.M.: Changes in gut microbiota control inflammationin obese mice through a mechanism involving GLP-2-drivenimprovement of gut permeability. Gut, 2009; 58: 1091-1103
    Google Scholar
  • 20. Carp R.I., Callahan S.M., Sersen E.A., Moretz R.C.: Preclinicalchanges in weight of scrapie-infected mice as a function of scrapieagent-mouse strain combination. Intervirology, 1984; 21: 61-69
    Google Scholar
  • 21. Carter J.K., Ow C.L., Smith R.E.: Rous-associated virus type 7 inducesa syndrome in chickens characterized by stunting and obesity.Infect. Immun., 1983; 39: 410-422
    Google Scholar
  • 22. Carvalho B.M., Guadagnini D., Tsukumo D.M., Schenka A.A.,Latuf-Filho P., Vassallo J., Dias J.C., Kubota L.T., Carvalheira J.B., SaadM.J.: Modulation of gut microbiota by antibiotics improves insulinsignalling in high-fat fed mice. Diabetologia, 2012; 55: 2823-2834
    Google Scholar
  • 23. Cazettes F., Cohen J.I., Yau P.L., Talbot H., Convit A.: Obesitymediatedinflammation may damage the brain circuit that regulatesfood intake. Brain Res., 2011; 1373: 101-109
    Google Scholar
  • 24. Cheymol G., Poirier J.M., Carrupt P.A., Testa B., WeissenburgerJ., Levron J.C., Snoeck E.: Pharmacokinetics of b-adrenoreceptorblockers in obese and normal volunteers. Br. J. Clin. Pharmacol.,1997; 43: 563-570
    Google Scholar
  • 25. Creely S.J., McTernan P.G., Kusminski C.M., Fisher F.M., Da SilvaN.F., Khanolkar M., Evans M., Harte A.L., Kumar S.: Lipopolysaccharideactivates an innate immune system response in human adiposetissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol.Metab., 2007; 292: E740- E747
    Google Scholar
  • 26. Cummings D.E., Overduin J.: Gastrointestinal regulation of foodintake. J. Clin. Invest., 2007; 117: 13-23
    Google Scholar
  • 27. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L.,Boschero A.C., Saad M.J., Velloso L.A.: Consumption of a fat-rich dietactivates a proinflammatory response and induces insulin resistancein the hypothalamus. Endocrinology, 2005; 146: 4192-4199
    Google Scholar
  • 28. Dhurandhar N.V., Israel B.A., Kolesar J.M., Mayhew G.F., CookM.E., Atkinson R.L.: Increased adiposity in animals due to a humanvirus. Int. J. Obes. Relat. Metab. Disord., 2000; 24: 989-996
    Google Scholar
  • 29. Dhurandhar N.V., Kulkarni P.R., Ajinkya S.M., Sherikar A.A., AtkinsonR.L.: Association of adenovirus infection with human obesity.Obes. Res., 1997; 5: 464-469
    Google Scholar
  • 30. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M., MagnessS., Jobin C., Lund P.K.: High-fat diet: bacteria interactions promoteintestinal inflammation which precedes and correlates withobesity and insulin resistance in mouse. PLoS One, 2010; 5: e12191
    Google Scholar
  • 31. Duca F.A., Swartz T.D., Sakar Y., Covasa M.: Increased oral detection,but decreased intestinal signaling for fats in mice lacking gutmicrobiota. PLoS One, 2012; 7: e39748
    Google Scholar
  • 32. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M.,Louis P., Flint H.J.: Human colonic microbiota associated with diet,obesity and weight loss. Int. J. Obes., 2008; 32: 1720-1724
    Google Scholar
  • 33. Erridge C., Attina T., Spickett C.M., Webb D.J.: A high-fat mealinduces low-grade endotoxemia: evidence of a novel mechanism ofpostprandial inflammation. Am. J. Clin. Nutr., 2007; 86: 1286-1292
    Google Scholar
  • 34. Evans A., Tolonen H., Hense H.W., Ferrario M., Sans S., KuulasmaaK., WHO MONICA Project: Trends in coronary risk factors in theWHO MONICA project. Int. J. Epidemiol., 2001; 30 (Suppl. 1): S35-S40
    Google Scholar
  • 35. Evans E.M., Rowe D.A., Racette S.B., Ross K.M., McAuley E.: Is thecurrent BMI obesity classification appropriate for black and whitepostmenopausal women? Int. J. Obes., 2006; 30: 837-843
    Google Scholar
  • 36. Farooqi I.S., O’Rahilly S.: Monogenic obesity in humans. Annu.Rev. Med., 2005; 56: 443-458
    Google Scholar
  • 37. Fernandez-Real J.M., Ferri M.J., Vendrell J., Ricart W.: Burden ofinfection and fat mass in healthy middle-aged men. Obesity, 2007;15: 245-252
    Google Scholar
  • 38. Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S.,Blaut M.: Absence of intestinal microbiota does not protect micefrom diet-induced obesity. Br. J. Nutr., 2010; 104: 919-929
    Google Scholar
  • 39. Franek E.: Postępy patofizjologii otyłości i jej głównych klinicznychskojarzeń. Med. Metab., 2001; 5: 41-54
    Google Scholar
  • 40. Friedman J.M.: Causes and control of excess body fat. Nature,2009; 459: 340-342
    Google Scholar
  • 41. Gangwisch J.E., Malaspina D., Boden-Albala B., Heymsfield S.B.:Inadequate sleep as a risk factor for obesity: analyses of the NHANESI. Sleep, 2005; 28: 1289-1296
    Google Scholar
  • 42. Goossens V.J., deJager S.A., Grauls G.E., Gielen M., Vlietinck R.F.,Derom C.A., Loos R.J., Rensen S.S., Buurman W.A., Greve J.W., van BaakM.A., Wolffs P.F., Bruggeman C.A., Hoebe C.J.: Lack of evidence forthe role of human adenovirus-36 in obesity in a European cohort.Obesity, 2011; 19: 220-221
    Google Scholar
  • 43. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., KeilbaughS.A., Hamady M., Chen Y.Y., Knight R., Ahima R.S., Bushman F., WuG.D.: High-fat diet determines the composition of the murine gutmicrobiome independently of obesity. Gastroenterology, 2009; 137:1716-1724.e2
    Google Scholar
  • 44. Hotamisligil G.S.: Inflammation and metabolic disorders. Nature,2006; 444: 860-867
    Google Scholar
  • 45. Jaworowska A,, Bazylak G.: Infekcje wirusowe w etiologii rozwojuotyłości. Postępy Hig. Med. Dośw., 2006; 60: 227-236
    Google Scholar
  • 46. Jia W., Li H., Zhao L., Nicholson J.K.: Gut microbiota: a potentialnew territory for drug targeting. Nat. Rev. Drug Discov., 2008;7: 123-129
    Google Scholar
  • 47. Jumpertz R., Le D.S., Turnbaugh P.J., Trinidad C., Bogardus C.,Gordon J.I., Krakoff J.: Energy-balance studies reveal associationsbetween gut microbes, caloric load, and nutrient absorption in humans.Am. J. Clin. Nutr., 2011; 94: 58-65
    Google Scholar
  • 48. Kaczmarczyk-Chałas K., Drygas W.: Trendy wysokości, ciężaruciała i wskaźnika nadwagi wśród dorosłych mieszkańców Łodzi, od 1972 do 1996 roku. Czynniki Ryzyka, 2002; 1: 38-43
    Google Scholar
  • 49. Kaji I., Karaki S., Tanaka R., Kuwahara A.: Density distributionof free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producingenteroendocrine L cells in human and rat lower intestine, and increasedcell numbers after ingestion of fructo-oligosaccharide. J.Mol. Histol., 2011; 42: 27-38
    Google Scholar
  • 50. Karaki S., Mitsui R., Hayashi H., Kato I., Sugiya H., Iwanaga T.,Furness J.B., Kuwahara A.: Short-chain fatty acid receptor, GPR43,is expressed by enteroendocrine cells and mucosal mast cells in ratintestine. Cell Tissue Res., 2006; 324: 353-360
    Google Scholar
  • 51. Kim F., Pham M., Maloney E., Rizzo N.O., Morton G.J., Wisse B.E.,Kirk E.A., Chait A., Schwartz M.W.: Vascular inflammation, insulinresistance, and reduced nitric oxide production precede the onsetof peripheral insulin resistance. Arterioscler. Thromb. Vasc. Biol.,2008; 28: 1982-1988
    Google Scholar
  • 52. Kleinridders A., Schenten D., Könner A.C., Belgardt B.F., MauerJ., Okamura T., Wunderlich F.T., Medzhitov R., Brüning J.C.: MyD88signaling in the CNS is required for development of fatty acid-inducedleptin resistance and diet-induced obesity. Cell Metab., 2009;10: 249-259
    Google Scholar
  • 53. Ley R.E.: Obesity and the human microbiome. Curr. Opin. Gastroenterol.,2010; 26: 5-11
    Google Scholar
  • 54. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D.,Gordon J.I.: Obesity alters gut microbial ecology. Proc. Natl. Acad.Sci. USA, 2005; 102: 11070-11075
    Google Scholar
  • 55. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I.: Human gut microbesassociated with obesity. Nature, 2006; 444: 1022-1023
    Google Scholar
  • 56. Li J., Tang Y., Cai D.: IKKβ/NF-κB disrupts adult hypothalamicneural stem cells to mediate a neurodegenerative mechanism ofdietary obesity and pre-diabetes. Nat. Cell Biol., 2012; 14: 999-1012
    Google Scholar
  • 57. Lin H.V., Frassetto A., Kowalik E.J.Jr., Nawrocki A.R., Lu M.M.,Kosinski J.R., Hubert J.A., Szeto D., Yao X., Forrest G., Marsh D.J.:Butyrate and propionate protect against diet-induced obesity andregulate gut hormones via free fatty acid receptor 3-independentmechanisms. PLoS One, 2012; 7: e35240
    Google Scholar
  • 58. Lin W.Y., Dubuisson O., Rubicz R., Liu N., Allison D.B., Curran J.E.,Comuzzie A.G., Blangero J., Leach C.T., Göring H., Dhurandhar N.V.:Long-term changes in adiposity and glycemic control are associatedwith past adenovirus infection. Diabetes Care, 2013; 36: 701-707
    Google Scholar
  • 59. Lyons M.J., Faust I.M., Hemmes R.B., Buskirk D.R., Hirsch J.,Zabriskie J.B.: A virally induced obesity syndrome in mice. Science,1982; 216: 82-85
    Google Scholar
  • 60. Maes H.H., Neale M.C., Eaves L.J.: Genetic and environmentalfactors in relative body weight and human adiposity. Behav. Genet.,1997; 27: 325-351
    Google Scholar
  • 61. Mandard S., Zandbergen F., van Straten E., Wahli W., Kuipers F.,Müller M., Kersten S.: The fasting-induced adipose factor/angiopoietin-likeprotein 4 is physically associated with lipoproteins and governsplasma lipid levels and adiposity. J. Biol. Chem., 2006; 281: 934-944
    Google Scholar
  • 62. Martinez J.A.: Body-weight regulation: causes of obesity. Proc.Nutr. Soc., 2000; 49: 337-345
    Google Scholar
  • 63. Mazur E., Małecka-Tendera E., Klimek K.: Czynniki ryzyka oty-łości u dzieci szkół podstawowych województwa podkarpackiegoCzęść II. Czynnik ryzyka otyłości u dziewcząt. Pediatr. Pol., 2003;10: 889-895
    Google Scholar
  • 64. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., BurcelinR.G., Corthesy I., Macé K., Chou C.J.: Gut microbiota modulationwith norfloxacin and ampicillin enhances glucose tolerance in mice.FASEB J., 2008; 22: 2416-2426
    Google Scholar
  • 65. Meng Q., Cai D.: Defective hypothalamic autophagy directs thecentral pathogenesis of obesity via the IκB kinase β (IKKβ)/NF-κBpathway. J. Biol. Chem., 2011; 286: 32324-32332
    Google Scholar
  • 66. Milanski M., Degasperi G., Coope A., Morari J., Denis R., CintraD.E., Tsukumo D.M., Anhe G., Amaral M.E., Takahashi H.K., Curi R.,Oliveira H.C., Carvalheira J.B., Bordin S., Saad M.J., Velloso L.A.: Saturatedfatty acids produce an inflammatory response predominantlythrough the activation of TLR4 signaling in hypothalamus: implicationsfor the pathogenesis of obesity. J. Neurosci., 2009; 29: 359-370
    Google Scholar
  • 67. Mischke M., Plösch T.: More than just a gut instinct – the potentialinterplay between a baby’s nutrition, its gut microbiome, andthe epigenome. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013;304: R1065-R1069
    Google Scholar
  • 68. Mitra A.K., Clarke K.: Viral obesity: fact or fiction? Obes. Rev.,2010; 11: 289-296
    Google Scholar
  • 69. Moraes J.C., Coope A., Morari J., Cintra D.E., Roman E.A., PauliJ.R., Romanatto T., Carvalheira J.B., Oliveira A.L., Saad M.J., VellosoL.A.: High-fat diet induces apoptosis of hypothalamic neurons. PLoSOne, 2009; 4: e5045
    Google Scholar
  • 70. Muccioli G.G., Naslain D., Bäckhed F., Reigstad C.S., Lambert D.M.,Delzenne N.M., Cani P.D.: The endocannabinoid system links gut microbiotato adipogenesis. Mol. Syst. Biol., 2010; 6: 392
    Google Scholar
  • 71. Na H.N, Kim H., Nam J.H.: Novel genes and cellular pathways relatedto infection with adenovirus-36 as an obesity agent in humanmesenchymal stem cells. Int. J. Obes., 2012; 36: 195-200
    Google Scholar
  • 72. Na H.N., Nam J.H.: Adenovirus 36 as an obesity agent maintainsthe obesity state by increasing MCP-1 and inducing inflammation.J. Infect. Dis., 2012; 205: 914-922
    Google Scholar
  • 73. Narayan O., Herzog S., Frese K., Scheefers H., Rott R.: Behavioraldisease in rats caused by immunopathological responses to persistentborna virus in the brain. Science, 1983; 220: 1401-1403
    Google Scholar
  • 74. National Heart Lung and Blood Institute; National Institute ofDiabetes and Digestive and Kidney Diseases. Obesity education initiative.In: Clinical guidelines on the identification, evaluation, andtreatment of overweight and obesity in adults: the evidence report.Bethesda, Md: National Heart, Lung, and Blood Institute in cooperationwith the National Institute of Diabetes and Digestive and KidneyDiseases; 1998. NIH publication No. 98-4083; 17. http://www.ncbi.nlm.nih.gov/nlmcatalog/100887711 (25.02.2014)
    Google Scholar
  • 75. Obesity: preventing and managing the global epidemic. Reportof a WHO consultation. World Health Organ Tech. Rep. Ser., 2000;894: 1-253
    Google Scholar
  • 76. Pasarica M., Shin A.C., Yu M., Ou Yang H.M., Rathod M., JenK.L., MohanKumar S., MohanKumar P.S., Markward N., DhurandharN.V.: Human adenovirus 36 induces adiposity, increases insulinsensitivity, and alters hypothalamic monoamines in rats. Obesity,2006; 14: 1905-1913
    Google Scholar
  • 77. Pertyński T., Połać I.: Otyłość u kobiet w okresie pomenopauzalnym.Menopauza, 2000; Instytut Centrum Zdrowia Matki Polki,Bibl. Naukowa Tom III: 85-92
    Google Scholar
  • 78. Pi-Sunyer F.X.: The obesity epidemic: pathophysiology and consequencesof obesity. Obes. Res., 2002; 10 (Suppl. 2): 97S-104S
    Google Scholar
  • 79. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-GiriA., Pennathur S., Baskin D.G., Heinecke J.W., WoodsS.C., Schwartz M.W., Niswender K.D.: Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance inrats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab., 2009;296: E1003-E1012
    Google Scholar
  • 80. Program POL-MONICA BIS Warszawa. Stan zdrowia ludnościWarszawy w roku 2001. Cz. 1. Podstawowe wyniki badania przekrojowego.Biblioteka Kardiologiczna. Warszawa 2002
    Google Scholar
  • 81. Quan W., Kim H.K., Moon E.Y., Kim S.S., Choi C.S., Komatsu M.,Jeong Y.T., Lee M.K., Kim K.W., Kim M.S., Lee M.S.: Role of hypothalamicproopiomelanocortin neuron autophagy in the control ofappetite and leptin response. Endocrinology, 2012; 153: 1817-1826
    Google Scholar
  • 82. Rabot S., Membrez M., Bruneau A., Gérard P., Harach T., MoserM., Raymond F., Mansourian R., Chou C.J.: Germ-free C57BL/6J miceare resistant to high-fat-diet-induced insulin resistance and havealtered cholesterol metabolism. FASEB J., 2010; 24: 4948-4959
    Google Scholar
  • 83. Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., ArgyropoulosG., Walts B., Pérusse L., Bouchard C.: The human obesity genemap: the 2005 update. Obesity, 2006; 14: 529-644
    Google Scholar
  • 84. Ravussin E., Gautier J.F.: Metabolic predictors of weight gain. Int.J. Obes. Relat. Metab. Disord., 1999; 23 (Suppl. 1): 37-41
    Google Scholar
  • 85. Rippe J.M.: The obesity epidemic: challenges and opportunities.J. Am. Diet. Assoc., 1998; 98: S5
    Google Scholar
  • 86. Rohrer J.E., Rohland B.M.: Psychosocial risk factors for obesityamong women in a family planning clinic. BMC Fam. Pract.,2004; 5: 20
    Google Scholar
  • 87. Rydén L., Standl E., Bartnik M., Van den Berghe G., Betteridge J.,de Boer M.J., Cosentino F., Jönsson B., Laakso M., Malmberg K., PrioriS., Ostergren J., Tuomilehto J., Thrainsdottir I., Vanhorebeek I. et al.:Guidelines on diabetes, pre-diabetes, and cardiovascular diseases:executive summary. The Task Force on Diabetes and CardiovascularDiseases of the European Society of Cardiology (ESC) and of theEuropean Association for the Study of Diabetes (EASD). Eur. HeartJ., 2007; 28: 88-136
    Google Scholar
  • 88. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., ManchesterJ.K., Hammer R.E., Williams S.C., Crowley J., YanagisawaM., Gordon J.I.: Effects of the gut microbiota on host adiposity aremodulated by the short-chain fatty-acid binding G protein-coupledreceptor, Gpr41. Proc. Natl. Acad. Sci. USA, 2008; 105: 16767-16772
    Google Scholar
  • 89. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C.,Hardt P.D.: Microbiota and SCFA in lean and overweight healthysubjects. Obesity, 2010; 18: 190-195
    Google Scholar
  • 90. Scott K.P., Gratz S.W., Sheridan P.O., Flint H.J., Duncan S.H.: Theinfluence of diet on the gut microbiota. Pharmacol. Res., 2013; 69:52-60
    Google Scholar
  • 91. Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., NajjarS., Nagaraja R., Orrú M., Usala G., Dei M., Lai S., Maschio A., BusoneroF., Mulas A. et al.: Genome-wide association scan shows geneticvariants in the FTO gene are associated with obesity-related traits.PLoS Genet., 2007; 3: e115
    Google Scholar
  • 92. Sefcíková Z., Kmet V., Bujnáková D., Racek L., Mozes S.: Developmentof gut microflora in obese and lean rats. Folia Microbiol.,2010; 55: 373-375
    Google Scholar
  • 93. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B.: Gut microbiotain health and disease. Physiol. Rev., 2010; 90: 859-904
    Google Scholar
  • 94. Shan L., Yu X.C., Liu Z., Hu Y., Sturgis L.T., Miranda M.L., Liu Q.:The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoproteinlipase activity through distinct mechanisms. J. Biol. Chem.,2009; 284: 1419-1424
    Google Scholar
  • 95. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S.: TLR4links innate immunity and fatty acid-induced insulin resistance. J.Clin. Invest., 2006; 116: 3015-3025
    Google Scholar
  • 96. Singh R.: Autophagy in the control of food intake. Adipocyte,2012; 1: 75-79
    Google Scholar
  • 97. Slomko H., Heo H.J., Einstein F.H.: Minireview: Epigenetics ofobesity and diabetes in humans. Endocrinology, 2012; 153: 1025-1030
    Google Scholar
  • 98. Spiegelman B.M., Flier J.S.: Obesity and the regulation of energybalance. Cell, 2001; 104: 531-543
    Google Scholar
  • 99. Taheri S., Lin L., Austin D., Young T., Mignot E.: Short sleepduration is associated with reduced leptin, elevated ghrelin, andincreased body mass index. PLoS Med., 2004; 1: e62
    Google Scholar
  • 100. Togo P., Osler M., Sorensen T.I., Heitmann B.L.: Food intakepatterns and body mass index in observational studies. Int. J. Obes.Relat. Metab. Disord., 2001; 25: 1741-1751
    Google Scholar
  • 101. Trovato G.M., Castro A., Tonzuso A., Garozzo A., Martines G.F.,Pirri C., Trovato F., Catalano D.: Human obesity relationship with Ad36adenovirus and insulin resistance. Int. J. Obes., 2009; 33: 1402-1409
    Google Scholar
  • 102. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O.,Hirabara S.M., Schenka A.A., Araújo E.P., Vassallo J., Curi R., Velloso L.A.,Saad M.J.: Loss-of-function mutation in Toll-like receptor 4 prevents diet-inducedobesity and insulin resistance. Diabetes, 2007; 56: 1986-1998
    Google Scholar
  • 103. Turnbaugh P.J., Bäckhed F., Fulton L., Gordon J.I.: Diet-inducedobesity is linked to marked but reversible alterations in the mousedistal gut microbiome. Cell Host Microbe, 2008; 3: 213-223
    Google Scholar
  • 104. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., DuncanA., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., EgholmM., Henrissat B., Heath A.C., Knight R., Gordon J.I:. A core gut microbiomein obese and lean twins. Nature, 2009; 457: 480-484
    Google Scholar
  • 105. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., MardisE.R., Gordon J.I.: An obesity-associated gut microbiome with increasedcapacity for energy harvest. Nature, 2006; 444: 1027-1031
    Google Scholar
  • 106. van de Sande-Lee S., Pereira F.R., Cintra D.E., Fernandes P.T.,Cardoso A.R., Garlipp C.R., Chaim E.A., Pareja J.C., Geloneze B., LiL.M., Cendes F., Velloso L.A.: Partial reversibility of hypothalamicdysfunction and changes in brain activity after body mass reductionin obese subjects. Diabetes, 2011; 60: 1699-1704
    Google Scholar
  • 107. Vangipuram S.D., Yu M., Tian J., Stanhope K.L., Pasarica M.,Havel P.J., Heydari A.R., Dhurandhar N.V.: Adipogenic human adenovirus-36reduces leptin expression and secretion and increasesglucose uptake by fat cells. Int. J. Obes., 2007; 31: 87-96
    Google Scholar
  • 108. Verdam F.J., Fuentes S., de Jonge C., Zoetendal E.G., Erbil R.,Greve J.W., Buurman W.A., de Vos W.M., Rensen S.S.: Human intestinalmicrobiota composition is associated with local and systemicinflammation in obesity. Obesity, 2013; 21: E607-E615
    Google Scholar
  • 109. Wang X., Ge A., Cheng M., Guo F., Zhao M., Zhou X., Liu L., YangN.: Increased hypothalamic inflammation associated with the susceptibilityto obesity in rats exposed to high-fat diet. Exp. DiabetesRes., 2012; 2012: 847246
    Google Scholar
  • 110. Wang Z.Q., Yu Y., Zhang X.H., Qin J., Floyd E.: Gene expressionprofile in human skeletal muscle cells infected with human adenovirustype 36. J. Med. Virol., 2012; 84: 1254-1266
    Google Scholar
  • 111. Yamada T., Hara K., Kadowaki T.: Association of adenovirus 36infection with obesity and metabolic markers in humans: a metaanalysisof observational studies. PLoS One, 2012; 7: e42031
    Google Scholar
  • 112. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D.: HypothalamicIKKβ/NF-κB and ER stress link overnutrition to energyimbalance and obesity. Cell, 2008; 135: 61-73
    Google Scholar
  • 113. Zhou J., Martin R.J., Tulley R.T., Raggio A.M., McCutcheon K.L,Shen L., Danna S.C., Tripathy S., Hegsted M., Keenan M.J.: Dietaryresistant starch upregulates total GLP-1 and PYY in a sustainedday-long manner through fermentation in rodents. Am. J. Physiol.Endocrinol. Metab., 2008; 295: E1160-E1166
    Google Scholar

Pełna treść artykułu

Przejdź do treści